BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6690042)

  • 1. Macrophage activation and generation of tumoricidal activity by liposome-associated human C-reactive protein.
    Barna BP; Deodhar SD; Gautam S; Yen-Lieberman B; Roberts D
    Cancer Res; 1984 Jan; 44(1):305-10. PubMed ID: 6690042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of tumoricidal effector cells by human C-reactive protein and muramyl tripeptide: a comparative study.
    Gautam S; Deodhar S
    J Biol Response Mod; 1989 Oct; 8(5):560-9. PubMed ID: 2795096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of resealed erythrocytes as delivery system for C-reactive protein (CRP) to generate macrophage-mediated tumoricidal activity.
    Gautam S; Barna B; Chiang T; Pettay J; Deodhar S
    J Biol Response Mod; 1987 Jun; 6(3):346-54. PubMed ID: 3598603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ; Fidler IJ
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage tumoricidal activity induced by human C-reactive protein.
    Zahedi K; Mortensen RF
    Cancer Res; 1986 Oct; 46(10):5077-83. PubMed ID: 3489521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
    J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein.
    Deodhar SD; James K; Chiang T; Edinger M; Barna BP
    Cancer Res; 1982 Dec; 42(12):5084-8. PubMed ID: 7139613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
    J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of human alveolar macrophage tumoricidal activity by C-reactive protein.
    Barna BP; Thomassen MJ; Wiedemann HP; Ahmad M; Deodhar SD
    J Biol Response Mod; 1988 Oct; 7(5):483-7. PubMed ID: 3183685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.
    Dinney CP; Bucana CD; Utsugi T; Fidler IJ; von Eschenbach AC; Killion JJ
    Cancer Res; 1991 Jul; 51(14):3741-7. PubMed ID: 1905975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.
    Mace K; Mayhew E; Mihich E; Ehrke MJ
    Cancer Res; 1988 Jan; 48(1):130-6. PubMed ID: 3257160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
    Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ activation of mouse lung macrophages by coadministration of liposomes containing the lipopeptide CGP 31362 and interleukin 2 involves interaction with T lymphocytes and natural killer cells.
    Utsugi T; Dinney CP; Killion JJ; Brown D; Fidler IJ
    Lymphokine Cytokine Res; 1991 Dec; 10(6):487-93. PubMed ID: 1804312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptide.
    Key ME; Talmadge JE; Fogler WE; Bucana C; Fidler IJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1198-98. PubMed ID: 6957661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
    Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
    J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human monocyte tumoricidal activity by C-reactive protein.
    Barna BP; James K; Deodhar SD
    Cancer Res; 1987 Aug; 47(15):3959-63. PubMed ID: 3038302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
    Fogler WE; Fidler IJ
    Cancer Res; 1985 Jan; 45(1):14-8. PubMed ID: 3855280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.